R. Casey

发表

Antiestrogenic action of dihydrotestosterone in mouse breast. Competition with estradiol for binding to the estrogen receptor.

J. Wilson, R. Casey, R W Casey, 1984, The Journal of clinical investigation.

Antiestrogenic Action of Dihydrotestosterone in Mouse Breast

Jean D. Wilson, R. Casey, 1984 .

ORIGINAL RESEARCH—ED PHARMACOTHERAPY: Can an Educational Program Optimize PDE5i Therapy? A Study of Canadian Primary Care Practices

J. Tarride, G. Brock, C. Rousseau, 2007 .

Treatment satisfaction with sildenafil in a Canadian real-life setting. A 6-month prospective observational study of primary care practices.

J. Tarride, G. Brock, C. Rousseau, 2007, The journal of sexual medicine.

Measuring quality of life: The development and initial validation of the Patient-Reported Erectile Function Assessment instrument

G. Torrance, J. Tarride, N. Ryan, 2006, International Journal of Technology Assessment in Health Care.

Vardenafil improves patient satisfaction with erection hardness, orgasmic function, and overall sexual experience, while improving quality of life in men with erectile dysfunction.

M. Thibonnier, T. Taylor, C. Donatucci, 2004, The journal of sexual medicine.

The effect of physician and patient education when combined with vardenafil treatment in Canadian males with erectile dysfunction: an open-label, factorial-designed, cluster-randomized clinical trial.

G. Brock, S. Carrier, P. Pommerville, 2008, The journal of sexual medicine.

Adding to the controversy: Pitfalls in the diagnosis of testosterone deficiency syndromes with questionnaires and biochemistry

R. Tremblay, A. Morales, A. Black, 2007, The aging male : the official journal of the International Society for the Study of the Aging Male.

Canadian male sexual health council survey to assess prevalence and treatment of premature ejaculation in Canada.

F. Bénard, J. Gajewski, S. Elliott, 2009, The journal of sexual medicine.

A comparison of etodolac (Ultradol) with acetaminophen plus codeine (Tylenol #3) in controlling post-surgical pain in vasectomy patients.

J. Zadra, R. Casey, H. Khonsari, 1997, Current medical research and opinion.

Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial.

J. Nickel, G. Brock, J. Downey, 2003, Urology.

A double‐blind randomized dose‐response study comparing daily doses of 5, 10 and 15 mg controlled‐release oxybutynin: balancing efficacy with severity of dry mouth

Z. Harsanyi, A. Darke, C. Andreou, 2006, BJU international.

Real-world evidence in patient-related outcomes (PROs) of metastatic castrate-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate plus prednisone (AA+P).

A. Zardan, A. Feifer, V. Fradet, 2018 .

Real-world evidence in patient-reported outcomes (PROs) of metastatic castrate-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate + prednisone (AA+P) across Canada: Final results of COSMiC.

J. Chin, A. Zardan, A. Feifer, 2020, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

CUAJ – Original Research Gotto et al PROs in mCRPCP: Final results of COSMiC

A. Zardan, A. Feifer, V. Fradet, 2020 .

Clinical Trials of Angiogenesis-Based Therapies: Overview and New Guiding Principles

Andrew Lee, William Li, V. Li, 1998 .

Development and initial validation of a new preference-based disease-specific health-related quality of life instrument for erectile function

G. W. Torrance, M. A. Keresteci, G. Torrance, 2004, Quality of Life Research.

A study in patients with erectile dysfunction comparing different formulations of prostaglandin E1. Alprostadil Study Group.

D. Vanderschueren, R. Heyrman, E. Keogh, 1995, The Journal of urology.

A multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of terazosin in the treatment of benign prostatic hyperplasia.

R W Casey, M M Elhilali, J. Trachtenberg, 1996, Urology.

The Erectile Function Visual Analog Scale (EF-VAS): a disease-specific utility instrument for the assessment of erectile function.

G. Torrance, J. Tarride, M. Keresteci, 2006, The Canadian journal of urology.

Diagnosis and management of benign prostatic hyperplasia in primary care.

F. Saad, J. Nickel, G. Brock, 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

Intracavernosal alprostadil is effective for the treatment of erectile dysfunction in diabetic men

F. Bénard, G. Brock, R. Rajatanavin, 2001, International Journal of Impotence Research.

Early symptom improvement of benign prostatic hyperplasia (BPH) treated with once daily alfuzosin.

F. Saad, M. Elhilali, L. Valiquette, 2005, The Canadian journal of urology.

UroLift system for relief of prostate obstruction under local anesthesia.

J. Giddens, J. Barkin, S. Gange, 2012, The Canadian journal of urology.

716 ZOLENDRONIC ACID REDUCES BONE LOSS IN MEN WITH PROSTATE CANCER RECEIVING GOSERELIN: 12 MONTH RESULTS

R. Casey, 2007 .

Zoledronic acid reduces bone loss in men with prostate cancer receiving goserelin

D. Reymond, M. Zarenda, W. Love, 2006 .

Opinion piece: Myths surrounding the investigation and treatment of erectile dysfunction

R. Casey, 2003 .

EFFECTS OF DAPOXETINE (DPX) FOR THE TREATMENT OF PREMATURE EJACULATION (PE) ON THE ERECTILE FUNCTION AND SCALES OF MOOD AND AFFECT

M. Rothman, D. Rivas, R. Mudumbi, 2008 .

Testosterone replacement therapy

R. Casey, 2003 .

Arterial gene therapy

William Li, V. Li, D. Tsakayannis, 1996, The Lancet.

Long term zoledronic acid during androgen blockade for prostate cancer.

J. Rochford, Z. Gesztesi, R. Casey, 2010, The Canadian journal of urology.

Canadian experience with high intensity focused ultrasound for the treatment of BPH.

K. W. Marich, L. Sullivan, P. Pommerville, 1999, The Canadian journal of urology.